Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-14

FDA Approved: TELMISARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan's supplemental application for telmisartan (generic), enabling the generic telmisartan product to be marketed under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)